Phenotypes of COPD patients with a smoking history in Central and Eastern Europe The POPE Study /
Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region. Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) stud...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2017
|
| Sorozat: | EUROPEAN RESPIRATORY JOURNAL
49 No. 5 |
| doi: | 10.1183/13993003.01446-2016 |
| mtmt: | 3231244 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/15188 |
| LEADER | 02630nab a2200361 i 4500 | ||
|---|---|---|---|
| 001 | publ15188 | ||
| 005 | 20190423104107.0 | ||
| 008 | 190423s2017 hu o 0|| angol d | ||
| 022 | |a 0903-1936 | ||
| 024 | 7 | |a 10.1183/13993003.01446-2016 |2 doi | |
| 024 | 7 | |a 3231244 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a angol | ||
| 100 | 1 | |a Koblizek Vladimir | |
| 245 | 1 | 0 | |a Phenotypes of COPD patients with a smoking history in Central and Eastern Europe |h [elektronikus dokumentum] : |b The POPE Study / |c Koblizek Vladimir |
| 260 | |c 2017 | ||
| 300 | |a Azonosító: 1601446-Terjedelem: 10 p | ||
| 490 | 0 | |a EUROPEAN RESPIRATORY JOURNAL |v 49 No. 5 | |
| 520 | 3 | |a Chronic obstructive pulmonary disease (COPD) represents a major health problem in Central and Eastern European (CEE) countries; however, there are no data regarding clinical phenotypes of these patients in this region. Participation in the Phenotypes of COPD in Central and Eastern Europe (POPE) study was offered to stable patients with COPD in a real-life setting. The primary aim of this study was to assess the prevalence of phenotypes according to predefined criteria. Secondary aims included analysis of differences in symptom load, comorbidities and pharmacological treatment. 3362 patients with COPD were recruited in 10 CEE countries. 63% of the population were nonexacerbators, 20.4% frequent exacerbators with chronic bronchitis, 9.5% frequent exacerbators without chronic bronchitis and 6.9% were classified as asthma - COPD overlap. Differences in the distribution of phenotypes between countries were observed, with the highest heterogeneity observed in the nonexacerbator cohort and the lowest heterogeneity observed in the asthma - COPD cohort. There were statistically significant differences in symptom load, lung function, comorbidities and treatment between these phenotypes. The majority of patients with stable COPD in CEE are nonexacerbators; however, there are distinct differences in surrogates of disease severity and therapy between predefined COPD phenotypes. Copyright ©ERS 2017. | |
| 700 | 0 | 1 | |a Milenkovic Branislava |e aut |
| 700 | 0 | 1 | |a Barczyk Adam |e aut |
| 700 | 0 | 1 | |a Tkacova Ruzena |e aut |
| 700 | 0 | 1 | |a Somfay Attila |e aut |
| 700 | 0 | 1 | |a Zykov Kirill |e aut |
| 700 | 0 | 1 | |a Tudoric Neven |e aut |
| 700 | 0 | 1 | |a Kostov Kosta |e aut |
| 700 | 0 | 1 | |a Zbozinkova Zuzana |e aut |
| 700 | 0 | 1 | |a Svancara Jan |e aut |
| 700 | 0 | 1 | |a Sorli Jurij |e aut |
| 700 | 0 | 1 | |a Krams Alvils |e aut |
| 700 | 0 | 1 | |a Miravitlles Marc |e aut |
| 700 | 0 | 1 | |a Valipour Arschang |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/15188/1/1601446.full.pdf |z Dokumentum-elérés |